Artivion AORT
NYSE AORT
$27.96 -0.86 (-2.98%)
As of: Aug 20, 2026 · 3:59 PM EDT

Artivion (AORT) Divestments (2016 - 2017)

Artivion's (AORT) quarterly Divestments came in at $740000.0 in Q1 2017, down 96.26% YoY from $19.8 million in Q1 2016, and down 96.26% on a QoQ basis from $19.8 million in Q1 2016.

Artivion (AORT) Divestments (2016 - 2017) Analysis & Trends

Artivion (AORT) has 2 years of Divestments data on file, last reported at $740000.0 in Q1 2017.

  • Quarterly Divestments fell 96.26% year-over-year to $740000.0 in Q1 2017, while the trailing twelve-month figure through Dec 2017 was $740000.0 (down 96.26% YoY) and the FY2017 annual result came in at $740000.0, down 96.26% from the prior year.
  • Divestments eased to $740000.0 in Q1 2017, from $19.8 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $19.8 million in Q1 2016 to a low of $740000.0 in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 153.43 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Artivion 1.36 Bn 1.28 Bn 80.52 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 740,000.00
Mar 31, 2016 19.80 Mn